Clinical Trials in San Francisco

Showing 6861-6880 of 12,991 trials

A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD

NCT01749215

The goal of this project is to improve the treatment of veterans with co-occurring alcohol dependence and posttraumatic stress disorder (PTSD). The PI and co-investigators will conduct a controlled clinical trial of topiramate for the treatment of these co-occurring disorders.

Alcohol DependencePosttraumatic Stress Disorder (PTSD)

University of California, San Francisco151 participantsStarted Feb 2013

San Francisco, California, United States

TERMINATEDPhase 4< 1 mile

Delayed Start to Ovarian Stimulation

NCT01614067

In couples with infertility secondary to Diminished Ovarian Reserve, the investigators hypothesize that a delayed start (7 day) to ovarian stimulation with an GnRH antagonist (Ganirelix) will improve oocyte maturation and quality, and improve pregnancy outcomes.

Diminished Ovarian ReserveInfertilityIn Vitro Fertilization

University of California, San Francisco30 participantsStarted May 2012

San Francisco, California, United States

COMPLETEDPhase 3< 1 mile

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

NCT00334958

To evaluate the effect of rufinamide on total partial seizure frequency in adolescent and adult participants (12 to 80 years, inclusive) with refractory partial onset seizures maintained on a maximum of 3 stable antiepileptic drugs (AEDs).

Epilepsy

Eisai Inc.356 participantsStarted Feb 2006

Mobile, Alabama, United States • Northport, Alabama, United States • Phoenix, Arizona, United States +74 more locations

A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD

Delayed Start to Ovarian Stimulation

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

Find Trials by Condition in San Francisco

Efficacy and Safety of SPD503 in Combination With Psychostimulants

SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study

(C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer

A Study of Oral Hymecromone and Hyaluronan Synthesis

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo

Impact of Curricular Transformation on Family Medicine Resident Burnout

Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder

Prevention of Recurrence of Diverticulitis

A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy

Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study

Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate